References
1. Hoy RF, Jeebhay MF, Cavalin C, et al. Current global perspectives on silicosis—Convergence of old and newly emergent hazards. Respirology. 2022;27(6):387-398. doi:10.1111/resp.14242
2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet. 2020;396(10258):1204-1222. doi:10.1016/S0140-6736(20)30925-9
3. Fernández Álvarez R, Martínez González C, Quero Martínez A, Blanco Pérez JJ, Carazo Fernández L, Prieto Fernández A. Guidelines for the diagnosis and monitoring of silicosis. Arch Bronconeumol. 2015;51(2):86-93. doi:10.1016/j.arbres.2014.07.010
4. Rupani MP. A mixed-methods study on impact of silicosis on tuberculosis treatment outcomes and need for TB-silicosis collaborative activities in India.Sci Rep. 2023;13(1):2785. doi:10.1038/s41598-023-30012-4
5. Chen FF, Tang HY, Yu F, et al. Renal involvement in a silicosis patient – case report and literature review. Ren Fail. 2019;41(1):1045-1053. doi:10.1080/0886022X.2019.1696209
6. Rom WN, Bitterman PB, Rennard SI, Cantin A, Crystal RG. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis. 1987;136(6):1429-1434. doi:10.1164/ajrccm/136.6.1429
7. Reiser KM, Last JA. Silicosis and fibrogenesis: fact and artifact. Toxicology. 1979;13(1):51-72.
8. Guarnieri G, Bizzotto R, Gottardo O, et al. Multiorgan accelerated silicosis misdiagnosed as sarcoidosis in two workers exposed to quartz conglomerate dust. Occup Environ Med. 2019;76(3):178-180. doi:10.1136/oemed-2018-105462
9. Shrestha AB, Yadav AK, Shrestha S, et al. A rare case of silicosis with hepatitis B infection. Ann Med Surg (Lond). 2022;84:104838. doi:10.1016/j.amsu.2022.104838
10. Tavakol E, Azari M, Zendehdel R, et al. Risk Evaluation of Construction Workers’ Exposure to Silica Dust and the Possible Lung Function Impairments.Tanaffos. 2017;16(4):295-303.
11. Mohammadi H, Farhang Dehghan S, Tahamtan A, Golbabaei F. Evaluation of potential biomarkers of exposure to crystalline silica: A case study in an insulator manufacturer. Toxicol Ind Health. 2018;34(7):491-498. doi:10.1177/0748233718770073
12. Hamaguchi Y, Nishizawa Y, Yasui M, et al. Intercellular Adhesion Molecule-1 and L-Selectin Regulate Bleomycin-Induced Lung Fibrosis. The American Journal of Pathology. 2002;161(5):1607-1618. doi:10.1016/S0002-9440(10)64439-2
13. Tuberculosis. Accessed July 15, 2023. https://www.who.int/southeastasia/health-topics/tuberculosis
14. Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1460-1462. doi:10.1164/ajrccm.150.5.7952577
15. Farazi A, Jabbariasl M. Silico-tuberculosis and associated risk factors in central province of Iran. Pan Afr Med J. 2015;20:333. doi:10.11604/pamj.2015.20.333.4993
16. Cao Z jie, Liu Y, Zhang Z, et al. Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A.Acta Pharmacol Sin. 2022;43(4):908-918. doi:10.1038/s41401-021-00706-4
17. Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther. 2014;349(2):209-220. doi:10.1124/jpet.113.208223
18. Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy. 2020;75(11):2805-2817. doi:10.1111/all.14202